The "First Singclean International Aesthetic Medicine Leadership Summit & Industry Cooperation" was grandly held at Jinmao Tower in Shanghai. With the theme of "Gathering Global Momentum · Defining Benchmarks", the summit brought together international supply chains such as BD Medical, a global leader in prefilled syringes, and HTL Biotechnology from France, a world-leading developer and supplier of aesthetic medical biopolymer materials, as well as industry leaders and experts from multiple countries. They jointly explored the construction and upgrading of the quality ecosystem in the aesthetic medicine industry. Chinese and foreign aesthetic medicine leaders jointly launched the "Quality Initiative" to build a new industry ecosystem. 

This initiative has not only consolidated the industry's consensus on high-quality development but also accurately identified the direction for innovative cooperation, enabling "Intelligent Manufacturing in China" to shine more brilliantly on the global map of aesthetic medicine.  

Singclean Medical has always adhered to the development philosophy of "Quality First", striving for excellence in every link of product R&D and production. Meanwhile, it upholds the core strategy that "service value outweighs product value". Through full industrial chain empowerment, it helps the industry create high-quality products with stronger market competitiveness, ultimately achieving mutual benefit and win-win results with partners and providing more reliable product guarantees for those seeking aesthetic improvements.